Aptar Pharma is expanding its digital healthsolutions driven by the impact of COVID-19 pandemic on patients and their ability to visit their physician or hospital.
 
Nordic Semiconductor will supply its Bluetooth Low Energy (Bluetooth LE) System-on-Chip (SoC), an essential component used in Aptar Pharma’s range of Digital Healthcare solutions. One such example is Aptar Pharma’s Connected Device for Metered Dose Inhalers (MDIs), a connected solution used with pressurized Metered Dose Inhalers to treat asthma & COPD.
 
Smart connected medical devices need a power source that can provide the necessary level of quality, performance and life to meet exacting industry demands. Nordic Semiconductor’s Bluetooth LE SoC enables Aptar Pharma’s smart Connected Device for MDIs to communicate all of the information generated on the Bluetooth LE-enabled device back to the patient’s smartphone, including date and time stamp, co-ordination information, inspiratory flow and more. Such features provide the patient and healthcare provider (HCP) with valuable insights into patient training, onboarding and adherence to their medication, as well as the potential for diagnostics data.
 
Nordic’s Bluetooth LE chip provides the necessary level of performance ensuring that Aptar Pharma has an offering that meets market needs.
 
“We are very pleased to partner with Nordic Semiconductor to support Aptar Pharma’s continued journey into digital health,” commented Sai Shankar, Vice President, Global Digital Healthcare Systems, Aptar Pharma. “Partnering with Nordic helps ensure that Aptar can react to the changing demands of the marketplace, ensuring that shared insights lead to our ever-evolving offering,” he added.
 
Aptar Pharma’s future digital healthcare plans include expansion into therapeutic areas such as Pain, CNS, allergy, oncology, diabetes and more.